Literature DB >> 28801282

[SOST knockdown promotes differentiation of osteoblasts MG63 and mesenchymal stem cells C3H10 in an in vitro model of bone metastasis of breast cancer].

Jia-Yi Huang1, Dan Guo.   

Abstract

OBJECTIVE: To investigate whether SOST is involved in breast cancer MDA-MB-231 cells-induced suppression of differentiation of osteoblast MG63 cells and mesenchymal stem C3H10 cells.
METHODS: SOST-specific small interfering RNA (siRNA) was transfected into breast cancer MDA-MB-231 cells, and the interfering efficiency was verified by RT-PCR. The supernatants were collected from MDA-MB-231 cells in routine culture, cells transfected with SOST siRNA via adenovirus, and cells transfected with empty adenoviral vectors and added in MG63 or C3H10 cell cultures. The changes in the expressions of OPG, OCN, OPN and IBSP in MG63 and C3H10 cells were detected using quantitative real-time PCR, and ALP activity was detected with ALP reading and ALP staining with the cells cultured in routine culture medium and cells in osteogenic induction medium as the negative and positive controls.
RESULTS: The adenovirus Ad-siSOST effectively knocked down the expression of SOST in MDA-MB-231 cells. MG63 cells and C3H10 cells cultured in osteogenic medium showed significantly upregulated expressions of the osteoblast markers OPG, OPN, OCN and IBSP (P<0.01), while co-culture with the supernatant of MDA-MB-231 cells obviously reduced the expressions of the osteoblast markers (P<0.01); the expression of the markers increased again in MG63 and C3H10 cells after treatment with the supernatant of MDA-MB-231 cells transfected with ad-siSOST (P<0.01). ALP activity in MG63 and C3H10 cells exhibited a similar pattern of variations in response to the treatments (P<0.01).
CONCLUSION: In the in vitro model of bone metastasis of breast cancer, the differentiation of MG63 or C3H10 cells is suppressed, which can be partly reversed by knocking down the expression of SOST in the bone metastasis microenvironment.

Entities:  

Year:  2017        PMID: 28801282      PMCID: PMC6765733     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  20 in total

1.  Crystal structures of the extracellular domain of LRP6 and its complex with DKK1.

Authors:  Zhihong Cheng; Travis Biechele; Zhiyi Wei; Seamus Morrone; Randall T Moon; Liguo Wang; Wenqing Xu
Journal:  Nat Struct Mol Biol       Date:  2011-10-09       Impact factor: 15.369

2.  Genetic evidence that SOST inhibits WNT signaling in the limb.

Authors:  Nicole M Collette; Damian C Genetos; Deepa Murugesh; Richard M Harland; Gabriela G Loots
Journal:  Dev Biol       Date:  2010-03-30       Impact factor: 3.582

3.  miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells.

Authors:  M Tomé; P López-Romero; C Albo; J C Sepúlveda; B Fernández-Gutiérrez; A Dopazo; A Bernad; M A González
Journal:  Cell Death Differ       Date:  2010-12-17       Impact factor: 15.828

Review 4.  Mimicking breast cancer-induced bone metastasis in vivo: current transplantation models and advanced humanized strategies.

Authors:  Laure Thibaudeau; Verena M Quent; Boris M Holzapfel; Anna V Taubenberger; Melanie Straub; Dietmar W Hutmacher
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 5.  Tumor microenvironment and the role of mesenchymal stromal cells.

Authors:  L Kucerova; S Skolekova
Journal:  Neoplasma       Date:  2013       Impact factor: 2.575

6.  Eight genes are highly associated with BMD variation in postmenopausal Caucasian women.

Authors:  Sjur Reppe; Hilde Refvem; Vigdis T Gautvik; Ole K Olstad; Per I Høvring; Finn P Reinholt; Marit Holden; Arnoldo Frigessi; Rune Jemtland; Kaare M Gautvik
Journal:  Bone       Date:  2009-11-14       Impact factor: 4.398

7.  Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus.

Authors:  Christine Hamann; Martina Rauner; Yvonne Höhna; Ricardo Bernhardt; Jan Mettelsiefen; Claudia Goettsch; Klaus-Peter Günther; Marina Stolina; Chun-Ya Han; Franklin J Asuncion; Michael S Ominsky; Lorenz C Hofbauer
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

8.  Expression of microRNA-30c and its target genes in human osteoblastic cells by nano-bioglass ceramic-treatment.

Authors:  A Moorthi; S Vimalraj; C Avani; Zhiming He; Nicola C Partridge; N Selvamurugan
Journal:  Int J Biol Macromol       Date:  2013-03-01       Impact factor: 6.953

9.  Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement.

Authors:  Rui Shu; Ding Bai; Tzongjen Sheu; Yao He; Xianrui Yang; Chaoran Xue; Yiruo He; Mengyuan Zhao; Xianglong Han
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

10.  Sclerostin expression in the subchondral bone of patients with knee osteoarthritis.

Authors:  Long Wu; Haohui Guo; Kening Sun; Xin Zhao; Tao Ma; Qunhua Jin
Journal:  Int J Mol Med       Date:  2016-09-19       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.